NCT07207096

Brief Summary

When the charity Homeopathy UK launched a new London based charitable clinic for Neurodegenerative Diseases (NDD), including Parkinson's Disease (PD), it was considered important to document patient's experiences of a high-quality complementary medicine clinic, to enable a greater understanding of the role of complementary medicine for PD. Routine clinical data, including a couple of questionnaires, is collected from consecutive patients with PD seen in the NDD clinic. Treatments provided are complementary to patients' usual medical treatment, and include homeopathy, herbalism, hypnosis, and healing. Patients may also be provided with self-help advice for lifestyle changes, mindfulness or meditation techniques, and dietary advice, as indicated for complementary therapy management of their condition. Consultations take place approximately every 3 months and patients complete questionnaires at the time of each consultation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
16mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Sep 2025Aug 2027

Study Start

First participant enrolled

September 19, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

September 26, 2025

Last Update Submit

September 26, 2025

Conditions

Keywords

homeopathyherbalismhypnosishealingcomplementary medicinelifestyleself-helpmindfulnessParkinson Disease

Outcome Measures

Primary Outcomes (2)

  • The MDS-sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

    The MDS-UPDRS has four parts: Part I (non-motor experiences of daily living), Part II (motor experiences of daily living), Part III (motor examination) and Part IV (motor complications). The majority of the MDS-UPDRS is completed by the clinic doctor. However Part IB is completed independently by the patient with or without the aid of the caregiver.

    At each consultation (approximately every 3 months)

  • Measure Your Own Medical Outcome Profile (MYMOP)

    MYMOP is a patient generated outcome measure consisting of 4 self-chosen items measured using a likert type scale of 0 (as good as it could be) to 6 (as bad as it could be): two symptoms considered most bothersome, an activity which the condition limits participation in, and wellbeing. It is a validated, personalized measure allowing patients to select their key concerns, and considered appropriate to capture the non-specific effects of complementary medicine.

    At each consultation (approximately every 3 months)

Interventions

complementary medicineCOMBINATION_PRODUCT

Complementary therapies provided include homeopathy, herbalism, hypnosis, and healing. Patients may also be provided with self-help advice for lifestyle changes, mindfulness or meditation techniques, and dietary advice, as indicated for complementary therapy management of their condition.

Also known as: homeopathy, herbalism, hypnosis, healing, self-help and lifestyle advice, mindfulness

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients who book an appointment for complementary therapy in the NDD clinic, and report a diagnosis of PD.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Feldy Community Centre

London, EX14 0XA, United Kingdom

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseParkinsonian Disorders

Interventions

Complementary TherapiesHomeopathyHypnosisMindfulness

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsMind-Body TherapiesPsychotherapyBehavioral Disciplines and ActivitiesCognitive Behavioral TherapyBehavior Therapy

Central Study Contacts

Yubraj Sharma, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate lecturer

Study Record Dates

First Submitted

September 26, 2025

First Posted

October 3, 2025

Study Start

September 19, 2025

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Anonymised data will be kept for a period of ten years on the St Mary's University Open Research Archive, which is a condition of St Mary's University

Locations